Managing cardiovascular risk factors: The gap between evidence and practice

PLoS Medicine

Volumn 2, Issue 5, 2005, Pages 0374-0375

  Turnbull, Fiona ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG COST; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; ARTICLE; CLINICAL PRACTICE; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; PHYSICIAN'S PRACTICE PATTERNS; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 22144447151     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020131     Document Type: Short Survey

References (8)

1. Ma J, Sehgal NL, Ayanian JZ, Stafford RS (2005) National trends in statin use by coronary heart disease risk category. PLoS Med 2: e123.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
3. Morgan S, Bassett KL, Wright JM, Yan L (2005) First-line first? Trends in thiazide prescribing for hypertensive seniors. PLoS Med 2: e80.
4. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group (2003) World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21: 1983-1992.
5. Hobbs F, Erhardt L (2002) Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: The Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 19: 596-604.
6. Law MR, Wald NJ (2002) Risk factor thresholds: Their existence under scrutiny. BMJ 324: 1570-1576.
7. Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood pressure lowering regimens on major cardiovascular events: Second cycle of prospectively designed overviews. Lancet 362: 1527-1535.
8. Larosa JC, Grundy SM, Waters DD, Shear C, Barter P, et al. (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. In press.